New HLA-DRB1 Allele Classification in Rheumatoid Arthritis
Author Information
Author(s): Gourraud Pierre-Antoine, Dieudé Philippe, Boyer Jean-Frédéric, Nogueira Leonor, Cambon-Thomsen Anne, Mazières Bernard, Cornélis François, Serre Guy, Cantagrel Alain, Constantin Arnaud
Primary Institution: Service d'Epidémiologie CHU Toulouse, INSERM, U558, Université Paul Sabatier Toulouse III
Hypothesis
Does a new classification of HLA-DRB1 alleles differentiate between predisposing and protective alleles for autoantibody production in rheumatoid arthritis?
Conclusion
The new classification of HLA-DRB1 alleles effectively distinguishes between predisposing and protective alleles for autoantibody production in early rheumatoid arthritis patients.
Supporting Evidence
- The new classification allows differentiation between predisposing and protective alleles for RF and ACPA production.
- S2 and S3P carriers had a higher frequency of autoantibodies compared to noncarriers.
- S3D and S1 carriers had a lower frequency of autoantibodies compared to noncarriers.
- The study confirms previous evidence of HLA-DRB1 gene polymorphisms' association with autoantibody production.
- The results support the hypothesis of an association between HLA-DRB1 gene polymorphisms and RF or ACPAs.
- The new classification provides a risk hierarchy for ACPA production in early RA patients.
- The study involved a well-defined cohort of early RA patients with rigorous inclusion criteria.
- Statistical analyses were performed using appropriate methods to ensure validity.
Takeaway
Scientists found a new way to group genes that can help tell if someone is more likely to get rheumatoid arthritis or if they are protected from it.
Methodology
The study involved 160 early rheumatoid arthritis patients, assessing autoantibodies and classifying HLA-DRB1 alleles using PCR methods.
Potential Biases
Potential bias may arise from the presence of adverse effect alleles in the control group affecting the association results.
Limitations
The study may have potential biases due to the presence of adverse effect alleles in the control group.
Participant Demographics
The cohort consisted of 120 women (75%) and 40 men (25%), with a mean age of 50.31 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% confidence intervals provided for odds ratios.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website